Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Infect Dis ; 217(1): 51-57, 2017 12 27.
Artigo em Inglês | MEDLINE | ID: mdl-29029120

RESUMO

Background: We evaluated the diagnostic usefulness of polymerase chain reaction (PCR) analysis for detecting varicella-zoster virus (VZV) infection and reactivation of VZV, using DNA extracted from saliva and plasma specimens obtained from subjects with suspected herpes zoster and from healthy volunteers during stressful and nonstressful conditions. Methods: There were 52 patients with a diagnosis of herpes zoster (group 1), 30 with a diagnosis of zoster-mimicking disease (group 2), and 27 healthy volunteers (group 3). Saliva and plasma samples were evaluated for VZV DNA by real-time PCR analysis. Results: Among patients with suspected herpes zoster (ie, patients in groups 1 and 2), the sensitivity of PCR analysis of salivary DNA for detecting VZV (88%; 95% confidence interval [CI], 74%-95%) was significantly higher than that of PCR analysis of plasma DNA (28%; 95% CI, 16%-44%; P < .001), whereas the specificity of PCR analysis of salivary DNA (100%; 95% CI, 88%-100%) was similar to that of PCR analysis of plasma DNA (100%; 95% CI, 78%-100%; P > .99). VZV DNA was not detected in saliva and plasma samples from group 3 (0%; 95% CI, 0%-14%). Conclusions: Real-time PCR analysis of salivary DNA is more sensitive than that of plasma DNA for detecting VZV among patients with suspected herpes zoster. We found no subclinical reactivation of VZV in group 3 following exposure to common stressful conditions.


Assuntos
DNA Viral/isolamento & purificação , Herpes Zoster/diagnóstico , Herpesvirus Humano 3/isolamento & purificação , Técnicas de Diagnóstico Molecular/métodos , Plasma/virologia , Reação em Cadeia da Polimerase em Tempo Real/métodos , Saliva/virologia , Adulto , Idoso , Idoso de 80 Anos ou mais , DNA Viral/genética , Feminino , Herpesvirus Humano 3/genética , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Sensibilidade e Especificidade , Adulto Jovem
2.
PLoS One ; 17(6): e0269770, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35696402

RESUMO

BACKGROUND: The aims of this study are to evaluate the cost-effectiveness of early dental visits (EDVs) and to investigate how regional deprivation impacts the economic evaluation. METHODS: This study used the South Korea National Health Insurance database, which included medical claim data and voluntary-based oral examination data. The subjects of this study included whole participants for oral examinations for infants and toddlers of the National Health Insurance Corporation. A retrospective cohort study was designed and measured all oral treatments, costs, and number of visits for 208,969 children (experimental group, 101,768; non- experimental group, 107,201) who underwent oral examination for infants and toddlers from 2007 to 2014. The cost-effectiveness was measured using the incremental cost-effectiveness ratio, and the T-health index was used as the measurement for effectiveness. In addition, the difference in the effect according to the level of regional deprivation was confirmed. RESULTS: The findings of this study showed that EDVs were cost-effective and that children who participated in EDVs had better oral health (T-health-2 index difference 0.32 point in most deprived regions) and needed 5 USD less costly dental treatments than those who did not have EDVs. The cost-effectiveness of EDVs varied according to the level of regional deprivation and was the highest in the most deprived regions. CONCLUSIONS: The study findings suggested that the provision of oral examination for infants and toddlers was a cost-effective dental policy. Additionally, EDVs were more effective in children who resided in the most deprived regions, a finding that will lead to the development of policy intervention to improve dental care despite spatial inequality for disadvantaged population groups. Regarding the distribution of dental hospitals/clinics, incentive based dental polices for either dental providers or patients are needed that will assure the delivery of dental care despite spatial inequality.


Assuntos
Programas Nacionais de Saúde , Saúde Bucal , Pré-Escolar , Análise Custo-Benefício , Humanos , Lactente , República da Coreia , Estudos Retrospectivos
3.
Eur Endod J ; 7(1): 20-26, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-35353067

RESUMO

OBJECTIVE: This study examined the survival rate of root canal treatment (RCT) and identified the factors affecting the survival/failure of RCT with respect to the patient's demographic, socioeconomic and dental healthcare factors. METHODS: The data of patients with RCT were analyzed using the 2002 patient data of the Korean National Health Insurance Service (KNHIS). The analysis included 1,193,666 patients, with 1,414,715 targeted teeth. Survival analysis was performed using the Kaplan-Meier method based on the occurrence of the untoward event. The proportional hazard of failure of RCT was measured using the Cox proportional hazard model and considering variables were gender, age, income, type of dental healthcare, number of visits for RCT, and type of teeth. RESULTS: The 11-year cumulative survival rate for non-surgical RCT teeth was 88.37%. The Cox proportional hazard model showed significantly lower females (HR 0.704; CI 1.022-1.079) than males. The hazard ratio (HR) of over 65 years (HR 2.959; CI 2.864-3.058) was higher than that of other groups. In addition, the HR varied according to the income level (medical beneficiary was the highest) and the type of dental healthcare (tertiary hospital was the lowest). CONCLUSION: Performing RCT survival analysis using representative data revealed that the demographic and socioeconomic factors of the patients affect the failure of RCT. This study can serve as the basis for improving the survival trend in RCT and provide important implications in clinical decision-making in endodontics.


Assuntos
Cavidade Pulpar , Endodontia , Adulto , Feminino , Seguimentos , Humanos , Masculino , República da Coreia/epidemiologia , Tratamento do Canal Radicular/métodos
4.
Tissue Eng Regen Med ; 18(2): 265-277, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33230801

RESUMO

BACKGROUND: Autophagy plays important roles in odontogenic differentiation of dental pulp cells (DPCs) in the developmental stage of tooth bud. Few studies have reported the role of autophagy during reparative dentin formation process. The objective of this study was to discover gene expression pattern correlated to autophagy and their role during odontogenic differentiation process in DPCs. METHODS: After tooth cavities were prepared on the mesial surface of lower first molar crown of rats. Odontogenic differentiation and reparative dentin formation were assessed based on detection of morphology change with hematoxylin and eosin staining. RESULTS: After tooth cavities were prepared on the mesial surface of lower first molar crown of rats, odontogenic differentiation and reparative dentin formation were assessed based on detection of morphology change with hematoxylin and eosin staining and dentin sialophosphoprotein (DSPP), whereas autophagy inhibitor 3-methyladenine (3MA) reversed. Results of quantitative polymerized chain reaction array of autophagosome formation related genes revealed that GABARAPL2 was prominently upregulated while expression of other ATG8 family members were moderately increased after tooth cavity preparation. In addition, human DPCs incubated in differentiation medium predominantly upregulated MAP1LC3C, which selectively decreased by 3MA but not by autophagy enhancer trehalose. Knock-down of MAP1LC3C using shRNA resulted in strong downregulation of dentin matrix protein 1 and DSPP as well-known odontogenic marker compared to knock-down of MAP1LC3B during odontogenic differentiation process of human DPCs. CONCLUSION: Our results suggest that MAP1LC3C plays a crucial role in odontogenic differentiation of human DPCs via regulating autophagic flux.


Assuntos
Polpa Dentária , Proteínas Associadas aos Microtúbulos , Animais , Proteínas Relacionadas à Autofagia , Diferenciação Celular , Células Cultivadas , Humanos , Masculino , Ratos , Ratos Sprague-Dawley
5.
Korean J Radiol ; 8(1): 9-14, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17277558

RESUMO

OBJECTIVE: We wanted to investigate the accuracy of contrast-enhanced MR imaging for the detection of lymph node metastases in a head and neck cancer rabbit model. MATERIALS AND METHODS: The metastatic lymph node model we used was created by inoculating VX2 tumors into the auricles of six New Zealand White rabbits. T1-weighted MR images were obtained before and after injecting gadopentetate dimeglumine at three weeks after tumor cell inoculation. The sizes, signal intensity ratios (i.e., the postcontrast signal intensities of the affected nodes relative to the adjacent muscle) and the enhancement patterns of 36 regional lymph nodes (parotid and caudal mandibular nodes) were evaluated on MR images and then compared with the histopathologic findings. RESULTS: No statistical difference was found between the sizes of 12 metastatic (10.5+/-3.2 mm) and 24 hyperplastic (8.0+/-3.6 mm) lymph nodes (p > 0.05). On the contrast-enhanced T1-weighted MR images, nine metastatic and four hyperplastic lymph nodes had peripheral high and central low signal intensity, whereas three metastatic and 20 hyperplastic lymph nodes had homogeneous high signal intensity. Using a signal intensity ratio less than one as a diagnostic criterion for a metastatic lymph node, the sensitivity, specificity and positive and negative predictive values of the enhanced MR images were 75% (9/12), 83% (20/24), 69% (9/13) and 87% (20/23), respectively, with areas under receiver-operating-characteristic curve values of 0.81. CONCLUSION: This experimental study confirms that metastatic and hyperplastic lymph nodes can be differentiated using MR images on the basis of the contrast uptake patterns, but that they cannot be differentiated using any particular size criteria.


Assuntos
Neoplasias de Cabeça e Pescoço/patologia , Metástase Linfática/patologia , Imageamento por Ressonância Magnética/métodos , Animais , Meios de Contraste , Modelos Animais de Doenças , Gadolínio DTPA , Valor Preditivo dos Testes , Curva ROC , Coelhos , Estudos Retrospectivos , Sensibilidade e Especificidade
6.
J Microbiol Biotechnol ; 25(3): 399-406, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25502824

RESUMO

In this study, we developed a composite filler comprising cross-linked hyaluronic acid (HA) and human collagen (COL) derived from the human umbilical cord with the aim of improving its biocompatibility and longevity compared with commercially available fillers. After HA/ COL composite fillers were made in two different ratios (10:1 and 5:1), the physical properties of the fillers were evaluated. The interior morphologies and in vivo weight change of these hydrogels were also characterized at 1-16 weeks after injection into mice. To evaluate their biocompatibility and durability in vivo, we injected the composite fillers into nude mice subcutaneously. The variations of injected gel weight were measured and compared with the commercial dermal fillers (Restylane and TheraFill). The composites showed improved or similar physical properties (complex viscosity of 19-22 × 10(5) cP, and injection force of 10- 12 N) over the commercial dermal fillers. Sixteen weeks following the injection, the ratio of remaining composite filler weight to initial weight (75.5 ± 16.9%; 10:1) was shown to be greater than that of the commercial fillers (43.2 ± 8.1%, Restylane; 12.3 ± 5.3%, TheraFill). In addition, immunohistochemical analysis with angiogenesis-related markers such as isolectin and vWF revealed newly formed blood vessels and cellular influx into the composite filler, which were not observed in the other fillers. These results clearly suggest that the HA/COL composite filler is a superior candidate for soft tissue reconstruction. The filler we developed may be a suitable candidate as an injectable dermal filler for tissue augmentation in humans.


Assuntos
Materiais Biocompatíveis , Colágeno , Preenchedores Dérmicos/administração & dosagem , Preenchedores Dérmicos/química , Ácido Hialurônico , Animais , Colágeno/administração & dosagem , Preenchedores Dérmicos/uso terapêutico , Humanos , Ácido Hialurônico/análogos & derivados , Hidrogéis , Injeções Subcutâneas , Lectinas/genética , Camundongos , Camundongos Nus , Cordão Umbilical/química , Viscosidade
7.
Colloids Surf B Biointerfaces ; 116: 318-26, 2014 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-24503353

RESUMO

Biomaterials that serve as scaffolds for cell proliferation and differentiation are increasingly being used in wound repair. In this study, the potential regenerative properties of a 3-D scaffold containing soluble silkworm gland hydrolysate (SSGH) and human collagen were evaluated. The scaffold was generated by solid-liquid phase separation and a freeze-drying method using a homogeneous aqueous solution. The porosity, swelling behavior, protein release, cytotoxicity, and antioxidative properties of scaffolds containing various ratios of SSGH and collagen were evaluated. SSGH/collagen scaffolds had a high porosity of 61-81% and swelling behavior studies demonstrated a 50-75% increase in swelling, along with complete protein release in the presence of phosphate-buffered saline. Cytocompatibility of the SSGH/collagen scaffold was demonstrated using mesenchymal stem cells from human umbilical cord. Furthermore, SSGH/collagen efficiently attenuated oxidative stress-induced cell damage. In an in vivo mouse model of wound healing, the SSGH/collagen scaffold accelerated wound re-epithelialization over a 15-day period. Overall, the microporous SSGH/collagen 3-D scaffold maintained optimal hydration of the exposed tissues and decreased wound healing time. These results contribute to the generation of advanced wound healing materials and may have future therapeutic implications.


Assuntos
Materiais Biocompatíveis/farmacologia , Colágeno Tipo I/farmacologia , Hidrolisados de Proteína/farmacologia , Cicatrização/efeitos dos fármacos , Animais , Materiais Biocompatíveis/química , Sobrevivência Celular/efeitos dos fármacos , Colágeno Tipo I/isolamento & purificação , Relação Dose-Resposta a Droga , Feminino , Humanos , Células-Tronco Mesenquimais/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Tamanho da Partícula , Porosidade , Solubilidade , Relação Estrutura-Atividade , Propriedades de Superfície
8.
Korean J Radiol ; 15(4): 411-22, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25053899

RESUMO

OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to produce trastuzumab-conjugated (Lipo[MNP@m-SiO2]-Her2Ab) nanoparticles to be utilized in vitro for the targeting of breast cancer. MATERIALS AND METHODS: The physiochemical characteristics of Lipo[MNP@m-SiO2] were assessed in terms of size, morphological features, and in vitro safety. The multimodal imaging properties of the organic dye incorporated into Lipo[MNP@m-SiO2] were assessed with both in vitro fluorescence and MR imaging. The specific targeting ability of trastuzumab (Her2/neu antibody, Herceptin®)-conjugated Lipo[MNP@m-SiO2] for Her2/neu-positive breast cancer cells was also evaluated with fluorescence and MR imaging. RESULTS: We obtained uniformly-sized and evenly distributed Lipo[MNP@m-SiO2] that demonstrated biological stability, while not disrupting cell viability. Her2/neu-positive breast cancer cell targeting by trastuzumab-conjugated Lipo[MNP@m-SiO2] was observed by in vitro fluorescence and MR imaging. CONCLUSION: Trastuzumab-conjugated Lipo[MNP@m-SiO2] is a potential treatment tool for targeted drug delivery in Her2/neu-positive breast cancer.


Assuntos
Anticorpos Monoclonais Humanizados/administração & dosagem , Antineoplásicos/administração & dosagem , Neoplasias da Mama/tratamento farmacológico , Nanopartículas de Magnetita/química , Nanoconjugados/química , Receptor ErbB-2 , Dióxido de Silício/síntese química , Células 3T3 , Animais , Neoplasias da Mama/química , Linhagem Celular Tumoral , Sistemas de Liberação de Medicamentos/métodos , Feminino , Compostos Férricos/química , Humanos , Lipossomos , Nanopartículas de Magnetita/administração & dosagem , Camundongos , Terapia de Alvo Molecular/métodos , Nanoconjugados/administração & dosagem , Nanopartículas/química , Receptor ErbB-2/imunologia , Dióxido de Silício/administração & dosagem , Dióxido de Silício/química , Trastuzumab
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA